2016 Apr 25. pii: S0041-008X(16)30089-8. doi: 10.1016/j.taap.2016.04.014. [Epub ahead of print]
Wohlman IM1, Composto GM1, Heck DE2, Heindel ND3, Lacey CJ3, Guillon CD3, Casillas RP4, Croutch CR4, Gerecke DR1, Laskin DL1, Joseph LB1, Laskin JD5.
Abstract
Vesicants including sulfur mustard (SM) and nitrogen mustard (NM) are bifunctional alkylating agents that cause skin inflammation, edema and blistering. This is associated with alterations in keratinocyte growth and differentiation. Endogenous cannabinoids, including N-arachidonoylethanolamine (anandamide, AEA) and 2-arachidonoyl glycerol (2-AG), are important in regulating inflammation, keratinocyte proliferation and wound healing. Their activity is mediated by binding to cannabinoid receptors 1 and 2 (CB1 and CB2), as well as peroxisome proliferator-activated receptor alpha (PPARα). Levels of endocannabinoids are regulated by fatty acid amide hydrolase (FAAH). We found that CB1, CB2, PPARα and FAAH were all constitutively expressed in mouse epidermis and dermal appendages. Topical administration of NM or SM, at concentrations that induce tissue injury, resulted in upregulation of FAAH, CB1, CB2 and PPARα, a response that persisted throughout the wound healing process. Inhibitors of FAAH including a novel class of vanillyl alcohol carbamates were found to be highly effective in suppressing vesicant-induced inflammation in mouse skin. Taken together, these data indicate that the endocannabinoid system is important in regulating skin homeostasis and that inhibitors of FAAH may be useful as medical countermeasures against vesicants.
Copyright © 2015. Published by Elsevier Inc.
Copyright © 2015. Published by Elsevier Inc.
KEYWORDS:
Endocannabinoids; Epidermis; FAAH; Inflammation; Sulfur mustard; Vesicants
- PMID:
- 27125198
- [PubMed – as supplied by publisher]